Genmab (GMAB) revenue

Revenue · fiscal 2025
$3.72B

Genmab (GMAB) reported revenue of $3.72B in fiscal 2025 (the year ended December 31, 2025). That is 19.2% higher than the $3.12B of fiscal 2024. Figures as of 18 Nov 2026, 09:56 UTC, from Yahoo Finance.

Key facts

Revenue, fiscal 2025
$3.72B
Change on fiscal 2024
+19.2%
Highest on record
$3.72Bfiscal 2025
Lowest on record
$2.09Bfiscal 2022
Fiscal years on record
42022–2025

Figures as of . Statements from Yahoo Finance. Amounts are in USD. Figures, not advice.

Genmab revenue, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was $3.72B in fiscal 2025 and the lowest $2.09B in fiscal 2022.

History · 4 fiscal years

Revenue by fiscal year

Genmab revenue, year by year

Genmab (GMAB) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$3.72B 19.2% up
2024$3.12B 30.6% up
2023$2.39B 14.5% up
2022$2.09B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

Revenue at health care companies of similar size

Revenue of Genmab and comparable companies
CompanyRevenueFiscal year
Mettler-Toledo International MTD$4.03B2025
Centene CNC$194.78B2025
Genmab GMAB$3.72B2025
Illumina ILMN$4.34B2025
ResMed RMD$5.65B2026
Zoetis ZTS$9.47B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on GMAB

Genmab, figure by figure

Genmab (GMAB) overview: price, valuation and scorecardAll health care companies by market value

Genmab revenue: questions and answers

What is Genmab's revenue?

Genmab (GMAB) reported revenue of $3.72B in fiscal 2025 (the year ended December 31, 2025). That is 19.2% higher than the $3.12B of fiscal 2024.

What are the highest and lowest revenue figures on record for Genmab?

Across the 4 fiscal years on record (2022–2025), the highest was $3.72B in fiscal 2025 and the lowest $2.09B in fiscal 2022.

How is Genmab's revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For Genmab it is on record here for 4 fiscal years, 2022 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Genmab (GMAB) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/GMAB/revenue

Underlying data: Yahoo Finance.